1. Home
  2. CVR vs MBAI Comparison

CVR vs MBAI Comparison

Compare CVR & MBAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Chicago Rivet & Machine Co.

CVR

Chicago Rivet & Machine Co.

N/A

Current Price

$10.71

Market Cap

10.4M

Sector

Industrials

ML Signal

N/A

Logo Check-Cap Ltd. Ordinary Share

MBAI

Check-Cap Ltd. Ordinary Share

N/A

Current Price

$1.56

Market Cap

12.0M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
CVR
MBAI
Founded
1920
2004
Country
United States
Israel
Employees
N/A
85
Industry
Industrial Machinery/Components
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
10.4M
12.0M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
CVR
MBAI
Price
$10.71
$1.56
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.7K
111.5K
Earning Date
05-08-2026
05-08-2026
Dividend Yield
1.03%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$27,890,260.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3.35
N/A
52 Week Low
$8.15
$1.31
52 Week High
$15.00
$3.92

Technical Indicators

Market Signals
Indicator
CVR
MBAI
Relative Strength Index (RSI) 54.07 42.39
Support Level $11.13 $1.38
Resistance Level $14.57 $1.91
Average True Range (ATR) 0.40 0.17
MACD 0.29 -0.03
Stochastic Oscillator 92.04 13.92

Price Performance

Historical Comparison
CVR
MBAI

About CVR Chicago Rivet & Machine Co.

Chicago Rivet & Machine Co is in the fastener industry in North America. The company operates in two segments namely fasteners and assembly equipment. Its fastener segment consists of the manufacture and sale of rivets, cold-formed fasteners, parts, and screw machine products. The assembly equipment segment consists mainly of the manufacture of automatic rivet setting machines, automatic assembly equipment, and parts and tools for such machines. The majority of revenue is from the fastener segment.

About MBAI Check-Cap Ltd. Ordinary Share

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.

Share on Social Networks: